Breakout stocks for Oct/03/2011

Overall markets look highly bearish. Strong selloff at the close on friday with a spike in VIX. My money is on the short side for the coming days. 

My Bears:
Merck & Co., Inc. (NYSE:MRK)
AT&T Inc. (NYSE:T)
Las Vegas Sands Corp. (NYSE:LVS)
Citigroup Inc. (NYSE:C)
Verizon Communications Inc. (NYSE:VZ)
Merck & Co., Inc. (NYSE:MRK)
CVS Caremark Corporation (NYSE:CVS)
PepsiCo, Inc. (NYSE:PEP)
The Home Depot, Inc. (NYSE:HD)
Accenture Plc (NYSE:ACN) 

Bulls:
Altair Nanotechnologies, Inc. (NASDAQ:ALTI)
Pulse Electronics Corp (NYSE:PULS)
Eastman Kodak Company (NYSE:EK) 

*Please do your own research before buying any stock listed here.
>> Subscribe to our posts.

Breakout stocks for Sep/29/2011

Can't go wrong if you are on the short side in this highly bearish world market conditions. in other words, you will have low probability of losing if you are short the market right now. Good luck!
Here's the list for Sep/29/2011.  

Bears:
AT&T Inc. (NYSE:T)
Las Vegas Sands Corp. (NYSE:LVS)
Citigroup Inc. (NYSE:C)
Verizon Communications Inc. (NYSE:VZ)
Merck & Co., Inc. (NYSE:MRK)
CVS Caremark Corporation (NYSE:CVS)
PepsiCo, Inc. (NYSE:PEP)
The Home Depot, Inc. (NYSE:HD)
Accenture Plc (NYSE:ACN) 

Bulls:
TeamStaff, Inc. (NASDAQ:TSTF)
Altair Nanotechnologies, Inc. (NASDAQ:ALTI)
CF Industries Holdings, Inc. (NYSE:CF)
Zale Corporation (NYSE:ZLC)
SYNNEX Corporation (NYSE:SNX) 

*Please do your own research before buying any stock listed here.
>> Subscribe to our posts.

Breakout stocks for Sep/28/2011

Since I am more inclined towards the downside for Sep/28, that's why have a bigger list of Bears than Bulls.

Bears:
AT&T Inc. (NYSE:T)
Citigroup Inc. (NYSE:C)
Verizon Communications Inc. (NYSE:VZ)
Merck & Co., Inc. (NYSE:MRK)
CVS Caremark Corporation (NYSE:CVS)
PepsiCo, Inc. (NYSE:PEP)
The Home Depot, Inc. (NYSE:HD)
Accenture Plc (NYSE:ACN)

Bulls:
Zale Corporation (NYSE:ZLC)
AdCare Health Systems, Inc. (AMEX:ADK)
SYNNEX Corporation (NYSE:SNX)
General Maritime Corp (NYSE:GMR)

*Please do your own research before buying any stock listed here.
>> Subscribe to our posts.

Just2trade.com is down

www.just2trade.com offers $2.50 trades and unlimited $0.50 option contracts. I had no problems with their trading platform except today when I am not able to access my account. I't's been down for me from the last 8 hrs. (Probably it's just me!). I can get to the login page, but can't access my account. Today is Tue, Sep/27/2011.

Luckily I have a few other accounts which I can trade with, but downtimes for a trading site doesn't show their dedication to be a leading player in this market.

Breakout stocks for the month - 2011/05/01

Hercules Offshore, Inc. (NASDAQ:HERO) - $6.28
American Superconductor Corporation (NASDAQ:AMSC) - $11.85
Yamana Gold Inc. (USA) (NYSE:AUY) - $12.71
Capstead Mortgage Corporation (NYSE:CMO) - $13.24
A-Power Energy Generation Systems, Ltd. (NASDAQ:APWR)- $4.05
CIBER, Inc. (NYSE:CBR) - $5.72
Delta Petroleum Corp. (NASDAQ:DPTR) - $0.837
Duke Energy Corporation (NYSE:DUK) - $18.65
Hornbeck Offshore Services, Inc. (NYSE:HOS) - $29.23
Continental Resources, Inc. (NYSE:CLR) - $68.68


OTC/Pink:
PIHN (Polaris International Holdings, Inc.)
CMGO (CMG Holdings, Inc.)
EVCA (Evcarco Inc.)
EMXC (eMax Holdings Corp.)
CCPRe (CaseyCorp Enterprises, Inc.)

*Please do your own research before buying any stock listed here.
>> Subscribe to our posts.

Trade alert: PCRX @ 7.03

Pacira Pharmaceuticals Inc (Public, NASDAQ:PCRX) 

Key points:
- IPO on Feb/02/2011 at $7
- Raised 36m at start
- Some insider buying
- Shares authorized to issue: 250m as of Feb/08
- Shares outstanding: 17m
- Float: <41% or <7m
- FDA for EXPAREL in third quarter of 2011 (july/28/2011), the company's most advanced investigational product candidate.
- Pacira plans to commercialize EXPAREL in the U.S. in the fourth quarter of 2011.

Current pps: $7.03
Link to chart: link
Link to google finance: link
Link to latest headlines: link
Company website: link
Analyst ratings: link

*Please do your own research before buying any stock listed here. Read disclaimer.

>> Subscribe to our posts.

Trade alert: SNTA

*Chart from www.stockcharts.com

Synta Pharmaceuticals Corp. (SNTA)

Key points:
- A Phase 2b/3 trial for ganetespib in combination with docetaxel in 2^nd-line advanced NSCLC patients is expected to initiate in Q2 of 2011. Results expected end of 2011 or early 2012.
- Phase 2b trial of elesclomol in NSCLC expected to begin in Q2 2011.
- Approved for funding of up to $1 million from U.S. Department of Defense for pre-clinical development of VDA in prostate cancer.
- As of December 31, 2010, the Company had $51.0 million in cash, enough to carry operations into 2012.

The stock is at a strong fib support at these levels. It might be seen as a great buy between $4.11 to $4.7. Watch for these supports for some great buying opportunities.

Current pps: $4.68
Link to chart: link
Link to google finance: link
Link to latest headlines: link
Company website: link
Shares outstanding: 40.5M
Float: 25.4M 

*Please do your own research before buying any stock listed here.

>> Subscribe to our posts.

Trade alert: DWA $29.75 [Feb/13/2011]

*Chart from www.stockcharts.com

Dreamworks Animation SKG, Inc. (Nasdaq: DWA )

Current pps: $29.75
Link to chart: link
Link to google finance: link
Link to latest headlines: link
Key Statistics: link 
Comparison with competitors (nasdaq.com): link
Company website: link

The beaten down stock price for Dreamworks Animation has shown some price movement in the last few days. Watch closely for the trend to reverse and a possible run-up for their next release.  

Some events to consider for price action:
- Feb 24, 2011:  Earnings conference call, post-market
- May 27, 2011: Kungfu Panda 2 release date

Shares outstanding: 84.26 M
Float: 65.7 M
Market cap – 2.5B (as of Feb/13/2011)

*Please do your own research before buying any stock listed here.

>> Subscribe to our posts.